Puma Biotechnology Inc Share Price
NASDAQ: PBYI | Small CapPuma Biotechnology Inc Stock Performance
Puma Biotechnology Inc Share Price Today
As of 18 November 2026, Puma Biotechnology Inc's share price is $7.16. The stock opened at $7.24, compared to its previous close of $7.30. During today's trading session, Puma Biotechnology Inc's share price traded between $6.92 and $7.24, with an average price of $7.08. Over the past 52 weeks, the stock has recorded a high of $11.37 and a low of $4.79. In terms of performance, Puma Biotechnology Inc's share price has risen by 0.42% over the last six months and is up 41.78% on a year-on-year basis.
Puma Biotechnology Inc Share Price Chart
Puma Biotechnology Inc Quarterly Profit & Loss
All figures in USD
Puma Biotechnology Inc Annual Profit & Loss
All figures in USD
About Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
Puma Biotechnology Inc Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $10.44 | $7.06 | -32.31% |
Oct 2026 | $9.96 | $10.43 | +4.98% |
Sep 2026 | $9.18 | $9.94 | +7.52% |
Aug 2026 | $7.84 | $9.24 | +16.67% |
Jul 2026 | $8.08 | $7.92 | -2.22% |
Jun 2026 | $7.04 | $8.10 | +13.60% |
May 2026 | $7.37 | $7.13 | -4.81% |
Apr 2026 | $6.46 | $7.49 | +17.40% |
Mar 2026 | $5.58 | $6.38 | +12.23% |
Feb 2026 | $6.47 | $5.68 | -12.40% |
Jan 2026 | $5.81 | $6.49 | +9.08% |
Dec 2025 | $4.97 | $5.95 | +17.82% |